Mivi Neuroscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mivi neuroscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mivi Neuroscience Today - Breaking & Trending Today

Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing


Published: Feb 04, 2021
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) Nemaura Medical Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces the appointment of Thomas Mortensen as head of E.U. commercial operations and marketing.
“Tom is an important addition to our team, as he will head up our operations in the E.U for our planned direct to consumer product. His extensive experience throughout Europe will help us determine the best way to position our products for country-specific audiences, and we look forward to his leadership and guidance as we ramp up our marketing activities,” said Faz Chowdhury, Ph.D., Nemaura’s CEO. ....

United States , Efaz Chowdhury , Thomas Mortensen , Jules Abraham , Sunshine Heart Inc , Nemaura Medical Inc , Circulite Inc , Exchange Commission , Bg Medicine Inc , Odense University , Southern Denmark Business School , Medi Cal , Roche Diabetes Care , Sunshine Heart , Mivi Neuroscience , Nemaura Medical , Premarket Approval Application , Statement Regarding Forward Looking Statements , United States Securities , Annual Report , Quarterly Reports , Current Reports , ஒன்றுபட்டது மாநிலங்களில் , ஃப்யாஸ் சவுத்ரி , தாமஸ் மோர்டென்சன் , சூரிய ஒளி இதயம் இன்க் ,

MIVI Neuroscience Secures Series B Funding


MIVI Neuroscience Secures Series B Funding
News provided by
Share this article
Share this article
EDEN PRAIRIE, Minn., Jan. 21, 2021 /PRNewswire/ MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including $35 million in new money plus the conversion of previously issued convertible notes.  The funding was led by a major multinational med-tech company and included participation from new investors Perceptive Advisors, Deerfield Management and Aphelion / Cardeation Capital as well as existing investors including Concord Health Partners.  Raymond James & Associates, Inc. acted as sole placement agent for the transaction. ....

United States , Bob Colloton , Concord Health Partners , Raymond James Associates Inc , Neuroscience Inc , Perceptive Advisors , Deerfield Management , Cardeation Capital , Concord Health , Raymond James , Aspiration System , Thrombectomy System , Mivi Neuroscience , Medical Equipment , Health Care Amp Hospitals , Venture Capital , ஒன்றுபட்டது மாநிலங்களில் , ஒத்திசைவு ஆரோக்கியம் கூட்டாளர்கள் , ரேமஂட் ஜேம்ஸ் கூட்டாளிகள் இன்க் , நரம்பியல் இன்க் , தீர்ப்பியல்ட் மேலாண்மை , ஒத்திசைவு ஆரோக்கியம் , ரேமஂட் ஜேம்ஸ் , ஆசை அமைப்பு , மருத்துவ உபகரணங்கள் , ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் ,